Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs? Article Swipe
Related Concepts
Counterpoint
Vancomycin
Clinical microbiology
Medicine
Microbiology
Intensive care medicine
Medical physics
Biology
Psychology
Bacteria
Staphylococcus aureus
Genetics
Pedagogy
Sara Revolinski
,
Christopher D. Doern
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1128/jcm.00239-21
· OA: W3127712948
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1128/jcm.00239-21
· OA: W3127712948
With numerous reported challenges to reporting MICs for vancomycin, clinical laboratories are attempting to identify accurate methods for MIC testing. However, the issues of poor reproducibility, accuracy, and clinical utility remain a challenge. In this Point-Counterpoint, Dr. Sara Revolinski discusses the pros of reporting MICs for vancomycin, while Dr. Christopher Doern argues for the use of caution.
Related Topics
Finding more related topics…